Moderna plunges as mRNA-based flu jab fails to ace existing shots
Moderna Inc shares tumbled 11% after early data showed that the company’s mRNA-based flu vaccine might not be strong enough to give it an edge over already approved flu vaccines ...
Explore the latest in lifestyle, culture, and trends with our Life & Style section. From travel guides, food and drink features, and health advice to fashion, entertainment, and cultural events, we cover the topics that shape modern life in Cyprus and beyond.